Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1

Oncogene

Volumn 27, Issue 29, 2008, Pages 4044-4055

  Tai, K Y ^a   Shieh, Y S ^b   Lee, C S ^a   Shiah, S G ^a   Wu, C W ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Axl; Brg 1; ERK; MMP 9; NF B

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; BRG1 PROTEIN; GELATINASE B; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE AX1; SILIBININ; WORTMANNIN;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE, TUMOR; CELL NUCLEUS; DNA HELICASES; ENZYME INDUCTION; ENZYME INHIBITORS; HUMANS; I-KAPPA B KINASE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MUTATION; NEOPLASM INVASIVENESS; NF-KAPPA B; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROTEIN BINDING; RECEPTOR PROTEIN-TYROSINE KINASES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 46449096930     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.57     Document Type: Article

References (38)

1. Banine F, Bartlett C, Gunawardena R, Muchardt C, Yaniv M, Knudsen ES et al. (2005). SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Res 65: 3542-3547.
2. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M et al. (2000). Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406: 536-540.
3. Budagian V, Bulanova E, Orinska Z, Thon L, Mamat U, Bellosta P et al. (2005). A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control. EMBO J 24: 4260-4270.
4. Chung BI, Malkowicz SB, Nguyen TB, Libertino JA, McGarvey TW. (2003). Expression of the proto-oncogene Axl in renal cell carcinoma. DNA Cell Biol 22: 533-540.
5. Craven RJ, Xu LH, Weiner TM, Fridell YW, Dent GA, Srivastava S et al. (1995). Receptor tyrosine kinases expressed in metastatic colon cancer. Int J Cancer 60: 791-797.
6. Demarchi F, Verardo R, Varnum B, Brancolini C, Schneider C. (2001). Gas6 anti-apoptotic signaling requires NF-kappa B activation. J Biol Chem 276: 31738-31744.
7. Dhanalakshmi S, Singh RP, Agarwal C, Agarwal R. (2002). Silibinin inhibits constitutive and TNFalpha-induced activation of NFkappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis. Oncogene 21: 1759-1767.
8. DiRenzo J, Shang Y, Phelan M, Sif S, Myers M, Kingston R et al. (2000). BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol 20: 7541-7549.
9. Fingleton B. (2006). Matrix metalloproteinases: roles in cancer and metastasis. Front Biosci 11: 479-491.
10. Fridell YW, Jin Y, Quilliam LA, Burchert A, McCloskey P, Spizz G et al. (1996). Differential activation of the Ras/extracellular-signal- regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase. Mol Cell Biol 16: 135-145.
11. Genersch E, Hayess K, Neuenfeld Y, Haller H. (2000). Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J Cell Sci 113(Part 23): 4319-4330.
12. Hafizi S, Dahlback B. (2006). Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases. Cytokine Growth Factor Rev 17: 295-304.
13. Hasanbasic I, Cuerquis J, Varnum B, Blostein MD. (2004). Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells. Am J Physiol Heart Circ Physiol 287: H1207-H1213.
14. Holland SJ, Powell MJ, Franci C, Chan EW, Friera AM, Atchison RE et al. (2005). Multiple roles for the receptor tyrosine kinase axl in tumor formation. Cancer Res 65: 9294-9303.
15. Ito T, Ito M, Naito S, Ohtsuru A, Nagayama Y, Kanematsu T et al. (1999). Expression of the Axl receptor tyrosine kinase in human thyroid carcinoma. Thyroid 9: 563-567.
16. Jacob AN, Kalapurakal J, Davidson WR, Kandpal G, Dunson N, Prashar Y et al. (1999). A receptor tyrosine kinase, UFO/Axl, and other genes isolated by a modified differential display PCR are overexpressed in metastatic prostatic carcinoma cell line DU145. Cancer Detect Prev 23: 325-332.
17. Jin S, Lu D, Ye S, Ye H, Zhu L, Feng Z et al. (2005). A simplified probe preparation for ELISA-based NF-kappaB activity assay. J Biochem Biophys Methods 65: 20-29.
18. Lakka SS, Jasti SL, Gondi C, Boyd D, Chandrasekar N, Dinh DH et al. (2002). Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene 21: 5601-5608.
19. Lay JD, Hong CC, Huang JS, Yang YY, Pao CY, Liu CH et al. (2007). Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL. Cancer Res 67: 3878-3887.
20. Liu Y, Denlinger CE, Rundall BK, Smith PW, Jones DR. (2006). Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA/p65. J Biol Chem 281: 31359-31368.
21. Ma Z, Shah RC, Chang MJ, Benveniste EN. (2004). Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol Cell Biol 24: 5496-5509.
22. Melaragno MG, Fridell YW, Berk BC. (1999). The Gas6/Axl system: a novel regulator of vascular cell function. Trends Cardiovasc Med 9: 250-253.
23. Meric F, Lee WP, Sahin A, Zhang H, Kung HJ, Hung MC. (2002). Expression profile of tyrosine kinases in breast cancer. Clin Cancer Res 8: 361-367.
24. Nakano T, Tani M, Ishibashi Y, Kimura K, Park YB, Imaizumi N et al. (2003). Biological properties and gene expression associated with metastatic potential of human osteosarcoma. Clin Exp Metastasis 20: 665-674.
25. Nemoto T, Ohashi K, Akashi T, Johnson JD, Hirokawa K. (1997). Overexpression of protein tyrosine kinases in human esophageal cancer. Pathobiology 65: 195-203.
26. Neubauer A, O'Bryan JP, Fiebeler A, Schmidt C, Huhn D, Liu ET. (1993). Axl, a novel receptor tyrosine kinase isolated from chronic myelogenous leukemia. Semin Hematol 30: 34.
27. Roberts CW, Orkin SH. (2004). The SWI/SNF complex - chromatin and cancer. Nat Rev Cancer 4: 133-142.
28. Sasaki T, Knyazev PG, Clout NJ, Cheburkin Y, Gohring W, Ullrich A et al. (2006). Structural basis for Gas6-Axl signalling. EMBO J 25: 80-87.
29. Shieh YS, Lai CY, Kao YR, Shiah SG, Chu YW, Lee HS et al. (2005). Expression of axl in lung adenocarcinoma and correlation with tumor progression. Neoplasia 7: 1058-1064.
30. Singh RA, Zhang JZ. (2004). Differential activation of ERK, p38, and JNK required for Th1 and Th2 deviation in myelin-reactive T cells induced by altered peptide ligand. J Immunol 173: 7299-7307.
31. Sun W, Fujimoto J, Tamaya T. (2004). Coexpression of Gas6/Axl in human ovarian cancers. Oncology 66: 450-457.
32. Tai KY, Shiah SG, Shieh YS, Kao YR, Chi CY, Huang E et al. (2007). DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression. Oncogene 26: 3989-3997.
33. Vajkoczy P, Knyazev P, Kunkel A, Capelle HH, Behrndt S, von Tengg-Kobligk H et al. (2006). Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc Natl Acad Sci USA 103: 5799-5804.
34. van Ginkel PR, Gee RL, Shearer RL, Subramanian L, Walker TM, Albert DM et al. (2004). Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res 64: 128-134.
35. Wang W. (2003). The SWI/SNF family of ATP-dependent chromatin remodelers: similar mechanisms for diverse functions. Curr Top Microbiol Immunol 274: 143-169.
36. Wu CW, Li AF, Chi CW, Lai CH, Huang CL, Lo SS et al. (2002). Clinical significance of AXL kinase family in gastric cancer. Anticancer Res 22: 1071-1078.
37. Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P et al. (2001). Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene 20: 8066-8074.
38. Zeigler ME, Chi Y, Schmidt T, Varani J. (1999). Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J Cell Physiol 180: 271-284.